. Show Affiliations »
Abstract
Mesh: See more » Biological ProductsDrug ApprovalGenetic EngineeringHumansTherapeutic EquivalencyUnited StatesUnited States Food and Drug Administration
Substances: See more » Biological Products
Year: 2012 PMID: 22364748 DOI: 10.1016/S0140-6736(12)60290-6
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321